Ryan C. Hutchinson

Ryan C. Hutchinson

Auto-generated profile, based on publicly available information

Ryan C. Hutchinson

Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2022 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
DJDiya B. Joseph
Diya B. Joseph
GHGervaise H. Henry
Gervaise H. Henry
AMAlicia Malewska
Alicia Malewska
JRJeffrey C. Reese
Jeffrey C. Reese
RMRyan J. Mauck
Ryan J. Mauck
DSDouglas W. Strand
Douglas W. Strand

1 July 2016 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
RHRyan C. Hutchinson
Ryan C. Hutchinson
VSVarun Sundaram
Varun Sundaram
MFMichael Folkert
Michael Folkert
YLYair Lotan
Yair Lotan

22 September 2016 in Cancer
Verified
Journal Article
Open access
PDF file
RHRyan Hutchinson
Ryan Hutchinson
AAAbdulhadi Akhtar
Abdulhadi Akhtar
JHJustin Haridas
Justin Haridas
DBDeepa Bhat
Deepa Bhat
CRClaus Roehrborn
Claus Roehrborn
YLYair Lotan
Yair Lotan
BACKGROUND: Since the US Preventive Services Task Force (USPSTF) recommended against prostate‐specific antigen (PSA) screening, there have been conflicting reports regarding the impact on the behavior of providers. This study analyzed real‐world data on PSA ordering and referral practices in the years surrounding the recommendation.METHODS: A whole‐institution sample of entered PSA orders and urology referrals was obtained from the electronic medical record. The study was performed at a tertiary referral center with a catchment in the southern United States. PSA examinations were defined as screening when they were ordered by providers with appointments in internal medicine, family medicine, or general internal medicine. Linear and quadratic regression analyses were performed, and joinpoint regression was used to assess for trend inflection points.RESULTS: Between January 2010 and July 2015, there were 275,784 unique ambulatory visits for men. There were 63,722 raw PSA orders, and 54,684 were evaluable. Primary care providers ordered 17,315 PSA tests and 858 urology referrals. The number of PSA tests per ambulatory visit, the number of referrals per ambulatory visit, the age at the time of the urology referral, and the proportion of PSA tests performed outside the recommended age range did not significantly change. The PSA value at the time of referral increased significantly (P = .022). Joinpoint analysis revealed no joinpoints in the analysis of total PSA orders, screening PSA tests, or examinations per 100 visits.CONCLUSIONS: In the years surrounding the USPSTF recommendation, PSA behavior did not change significantly. Patients were referred at progressively higher average PSA levels. The implications for prostate cancer outcomes from these trends warrant further research into provider variables associated with actual PSA utilization. Cancer 2016;122:3785–3793. © 2016 American Cancer Society.

10 August 2020 in Cancer
Verified
Journal Article
Closed access
PDF file
NCNathan Chertack
Nathan Chertack
RGRashed A. Ghandour
Rashed A. Ghandour
NSNirmish Singla
Nirmish Singla
YFYuval Freifeld
Yuval Freifeld
RHRyan C. Hutchinson
Ryan C. Hutchinson
ABAditya Bagrodia
Aditya Bagrodia

14 November 2017 in Nature Reviews Urology
Verified
Journal Article
Closed access
PDF file
SWSolomon L. Woldu
Solomon L. Woldu
RHRyan C. Hutchinson
Ryan C. Hutchinson
LKLaura-Maria Krabbe
Laura-Maria Krabbe
OSOner Sanli
Oner Sanli
VMVitaly Margulis
Vitaly Margulis

19 February 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
DJDiya B. Joseph
Diya B. Joseph
GHGervaise H. Henry
Gervaise H. Henry
AMAlicia Malewska
Alicia Malewska
NINida S. Iqbal
Nida S. Iqbal
HRHannah Ruetten
Hannah Ruetten
DSDouglas W. Strand
Douglas W. Strand
Castration-insensitive epithelial progenitors capable of regenerating the prostate are concentrated in the proximal region close to the urethra, but the identification of these cells has been limited to individual cell surface markers. Here, we use single cell RNA sequencing (scRNA-seq) to obtain a cellular anatomy of the mouse prostate and urethra and create a comparative map with the human. These data reveal that previously identified facultative progenitors marked by TROP2, Sca-1, KRT4, and PSCA are actually luminal epithelia of the urethra that extend into the proximal prostate. These mouse urethral cells are the human equivalent of previously identified club and hillock urethral cells. Castration decreases androgen-dependent prostate luminal epithelia as expected, but TROP2+ urethral luminal epithelia survive and expand into the prostate. Benign prostatic hyperplasia (BPH) has long been considered an ‘embryonic reawakening’, but the cellular origin of peri-urethral growth is unclear. We use scRNA-seq and flow cytometry to demonstrate an increase in urethral luminal epithelia within glandular nodules from patients with BPH, which are further enriched in patients treated with a 5 alpha reductase inhibitor. These data demonstrate that the putative prostate progenitors enriched by castration in the proximal prostate are an expansion of urethral luminal epithelia and that these cells may play an important role in the etiology of human BPH. Significance Statement: The prostate involutes after castration, but regrows to its original size with androgen replenishment. This observation prompted the search for a castration-insensitive prostate progenitor. Here, Joseph et al . produce a comparative cellular atlas of the prostate and urethra in the mouse vs. human, discovering an equivalent urethral luminal epithelial cell type that extends into the proximal prostatic ducts and expresses previously identified markers of facultative prostate progenitors. Urethral luminal epithelia are established before prostate budding in human and mouse development, and expand after castration in the mouse and after 5 alpha reductase inhibitor treatment in human BPH. These data suggest that luminal epithelia of the urethra are castration-insensitive cells of proximal ducts that may act as progenitors in human BPH.